Acrivastine

Catalog No. A17746

Acrivastine (BW825C) is a short acting histamine 1 receptor antagonist for the treatment of allergic rhinitis.

Technical details

Catalog Num	A17746
M. Wt	348.44
Formula	C22H24N2O2
Purity	>98%
Storage	at -20°C 3 years Powder
CAS No.	87848-99-5
Synonyms	Acrivastine; BW 825C
SMILES	O=C(O)/C=C/C1=NC(/C(C2=CC=C(C)C=C2)=C/CN3CCCC3)=CC=C1

Biological Activity

Acrivastine (BW825C) is a short acting histamine 1 receptor antagonist for the treatment of allergic rhinitis.

Solubility *

In vitro	DMSO	10 mg/mL (28.69 mM)
	Water
	Ethanol
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Preparing Stock Solutions

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
0.1 mM	28.7 mL	143.5 mL	286.99 mL
0.5 mM	5.74 mL	28.7 mL	57.4 mL
1 mM	2.87 mL	14.35 mL	28.7 mL
5 mM	0.57 mL	2.87 mL	5.74 mL

*The above data is based on the productmolecular weight 348.44. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Adooq Bioscience

Acrivastine

Technical details

Biological Activity

Solubility *

Preparing Stock Solutions